Survival in Primary Myelofibrosis: A Population-based Analysis in the Netherlands

Autor: Stefanie Slot, Avinash G. Dinmohamed, Otto Visser, Peter A. W. te Boekhorst, Sonja Zweegman

Publikováno v: HemaSphere, Vol 5, Iss 7, p e595 (2021)

Externí odkaz: https://doaj.org/article/63b2ba10b3264ce284e909f6d531b134

EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis

Autor: Alessandro M. Vannucchi, Peter A. W. te Boekhorst, Claire N. Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer-Perrard, Minghui Duan, Nathalie Francillard, Betty Molloy, Monika Wroclawska, Heinz Gisslinger

Publikováno v: Haematologica, Vol 104, Iss 5 (2019)

EEXPAND (phase Ib, dose-finding study) evaluated the starting dose of ruxolitinib in patients with myelofibrosis with baseline platelet counts of 50-99×109/L. The study consisted of dose-escalation and safety-expansion phases. Based on the baseline

Externí odkaz: https://doaj.org/article/dcdd30fc08a34d069d9bc9af3fd3e65b

Late excess mortality in essential thrombocythemia

Autor: Tom S. M. Posthuma, Peter A. W. te Boekhorst, Otto Visser, Avinash G. Dinmohamed

Publikováno v: Leukemia, 36(1), 275-278. Nature Publishing Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b7b8f66ce8478197a3657e5381818a2
https://doi.org/10.1038/s41375-021-01372-5

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Autor: Sonja Zweegman, Shanti Natarajan-Amé, Francesco Passamonti, Raajit K. Rampal, Moshe Talpaz, Daobin Zhou, Kelly McCaul, Mary Frances McMullin, Candido E. Rivera, Hiroshi Kawabata, Günther Gastl, H. Joachim Deeg, Heinz Gisslinger, Angela Hamblin, Vincent Ribrag, Reinier Raymakers, John Catalano, P. Mineur, Fabrizio Pane, Giuseppe Saglio, Jean Loup Demory, Josef T. Prchal, Qian Jiang, Kudrat Abdulkadyrov, Emmanuel C. Besa, Richard F. Schlenk, Gary J. Schiller, John T. Reilly, Adam J. Mead, Robert Peter Gale, William Stevenson, Gemma Buck, Kazuma Ohyashiki, Dominique Bordessoule, Mark Drummond, Jianyong Li, Ayalew Tefferi, Ting Liu, Tomoko Hata, Jianhua Zhong, Juan Carlos Hernandez Boluda, Damiano Rondelli, Norio Komatsu, John Mascarenhas, Zhixiang Shen, Timothy Devos, Alessandro M. Vannucchi, Katsuto Takenaka, Randall Brown, Haifa K. Al-Ali, Thomas J. Nevill, Jen Chin Wang, Daniel Tesfa, Jennifer O'Sullivan, Andrew Turner, Guanlin Wang, Galina Salogub, Claire N. Harrison, Dragana Milojkovic, Giovanni Barosi, James W. Vardiman, Peter A. W. te Boekhorst, Ruben A. Mesa, Jan Van Droogenbroeck, Manana Sokolova, Vikas Gupta, Lennart Nilsson, Andrey Zaritskiy, Nikolaos Barkas, Werner Linkesch, Mario Cazzola, Jean-Jacques Kiladjian, Ramon V. Tiu, Kiyoshi Ando, Onima Chowdhury, Emilio Ojeda, Martin Griesshammer, Christian Recher, Alessandro Rambaldi, Francisco Cervantes, Giorgina Specchia

Publikováno v: Leukemia
for the RESUME trialists 2020, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia . https://doi.org/10.1038/s41375-020-0979-6, https://doi.org/10.1038/s41375-020-0979-6
Chowdhury, O, O’Sullivan, J, Barkas, N, Wang, G, Buck, G, Hamblin, A, Tefferi, A, Al-Ali, H K, Barosi, G, Devos, T, Gisslinger, H, Jiang, Q, Kiladjian, J J, Mesa, R, Passamonti, F, Ribrag, V, Schiller, G, Vannucchi, A M, Zhou, D, McMullin, M F, Zhong, J, Gale, R P, Mead, A J, Catalano, J, Stevenson, W, Gastl, G, Linkesch, W, Van Droogenbroeck, J, Mineur, P, Gupta, V, Turner, A, Nevill, T, Li, J, Shen, Z, Liu, T, Bordessoule, D, Natarajan-Amé, S, Recher, C, Demory, J L, Schlenk, R, Griesshammer, M, Cazzola, M, Saglio, G, Specchia, G, Rambaldi, A, Pane, F, Zweegman, S, te Boekhorst, P, Raymakers, R, Abdulkadyrov, K, Sokolova, M, Salogub, G, Zaritskiy, A, Cervantes, F, Boluda, J C H, Ojeda, E, Tesfa, D, Nilsson, L, Drummond, M, Reilly, J, Harrison, C, Milojkovic, D, Rivera, C, Besa, E, Deeg, H J, Mascarenhas, J, Prchal, J, Tiu, R, Talpaz, M, Wang, J C, Rampal, R, Rondelli, D, McCaul, K, Brown, R, Komatsu, N, Ohyashiki, K, Ando, K, Kawabata, H, Takenaka, K, Hata, T, Vardiman, J & for the RESUME trialists 2021, ' Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide ', Leukemia, vol. 35, no. 4, pp. 1197-1202 . https://doi.org/10.1038/s41375-020-0979-6
Leukemia, 35(4), 1197-1202. Nature Publishing Group

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0edc47d8d0334cb53e4de6e4bb4f5b9f
http://www.scopus.com/inward/record.url?scp=85089142992&partnerID=8YFLogxK

The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia

Autor: Jaap Jan Zwaginga, Nan van Geloven, Anneke Brand, Pieter F. van der Meer, Jeroen Eikenboom, Peter A. W. te Boekhorst, J. L. Kerkhoffs, Paula F. Ypma, Erik A M Beckers

Publikováno v: British Journal of Haematology, 189(1), 171-181
British Journal of Haematology
British Journal of Haematology, 189(1), 171-181. Wiley

In daily haematological practice, predicting bleeding in thrombocytopenic patients is difficult, and clinicians adhere to transfusion triggers to guide patients through the aplastic phase of chemotherapy. Platelet count is not the only determinant of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c319c34b3ed062da02fe911963a553a
https://doi.org/10.1111/bjh.16291